Just weeks after our debut as an independent, publicly traded company, Sandoz was named “Company of the Year” in the generics and biosimilar medicines industry.
In recognition of his achievements at Sandoz and for the industry as a whole, Sandoz CEO Richard Saynor took home the “Leader of the Year” award, his third win in this category in four years.
Sandoz also won “Business Development of the Year” for its far-reaching biosimilar collaboration with Just Evotech.
👉 Sandoz takes home 3 times “Gold” at 2023 Generics Bulletin Awards: Sandoz wins Company of the Year, Leader of the Year and Business Development of the Year awards | Sandoz
